These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14751139)

  • 41. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.
    DiSilvestro PA; Walker JL; Morrison A; Rose PG; Homesley H; Warshal D;
    Gynecol Oncol; 2006 Dec; 103(3):1038-42. PubMed ID: 16889823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer.
    Kalaghchi B; Abdi R; Amouzegar-Hashemi F; Esmati E; Alikhasi A
    Asian Pac J Cancer Prev; 2016; 17(S3):287-91. PubMed ID: 27165240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
    Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
    J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma.
    Tang J; Tang Y; Yang J; Huang S
    Gynecol Oncol; 2012 May; 125(2):297-302. PubMed ID: 22307061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma.
    Mori T; Hosokawa K; Kinoshita Y; Watanabe A; Honjo H
    Int J Gynecol Cancer; 2008; 18(1):85-9. PubMed ID: 17587314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
    Tesfai FM; Kroep JR; Gaarenstroom K; De Kroon C; Van Loenhout R; Smit V; Trimbos B; Nout RA; van Poelgeest MIE; Beltman JJ
    Int J Gynecol Cancer; 2020 Jan; 30(1):115-121. PubMed ID: 31744889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
    Takekuma M; Hirashima Y; Ito K; Tsubamoto H; Tabata T; Arakawa A; Itani Y; Furukawa N; Murakoshi H; Takeuchi S
    Gynecol Oncol; 2012 Sep; 126(3):341-5. PubMed ID: 22609108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concurrent chemo-irradiation with weekly cisplatin and paclitaxel in the treatment of locally advanced squamous cell carcinoma of cervix: a phase II study.
    Varghese SS; Ram TS; Pavamani SP; Thomas EM; Jeyaseelan V; Viswanathan PN
    J Cancer Res Ther; 2014; 10(2):330-6. PubMed ID: 25022387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trial.
    Dipetrillo T; Suntharalingam M; Ng T; Fontaine J; Horiba N; Oldenburg N; Perez K; Birnbaum A; Battafarano R; Burrows W; Safran H
    Am J Clin Oncol; 2012 Feb; 35(1):64-7. PubMed ID: 21297434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study.
    Walker JL; Morrison A; DiSilvestro P; von Gruenigen VE;
    Gynecol Oncol; 2009 Jan; 112(1):78-84. PubMed ID: 19010522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
    Yamaguchi S; Nishimura R; Yaegashi N; Kiguchi K; Sugiyama T; Kita T; Kubushiro K; Kokawa K; Hiura M; Mizutani K; Yamamoto K; Takizawa K
    Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
    Nagao S; Yamamoto K; Oishi T; Yamaguchi S; Takehara K; Shimada M; Kigawa J
    Int J Clin Oncol; 2021 Jan; 26(1):207-215. PubMed ID: 32960420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer.
    Chitapanarux I; Tonusin A; Sukthomya V; Charuchinda C; Pukanhapan N; Lorvidhaya V
    Gynecol Oncol; 2003 Jun; 89(3):402-7. PubMed ID: 12798702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer.
    Martínez-Fernández MI; Legaspi Folgueira J; Valtueña Peydró G; Cambeiro M; Espinós J; Aramendía JM; Minguez-Milio JA; Martínez-Monge R
    Int J Gynecol Cancer; 2016 Jul; 26(6):1162-8. PubMed ID: 27327153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
    Tabata T; Nishiura K; Yanoh K; Okugawa T; Obata H; Tanaka K; Toyoda N
    Int J Clin Oncol; 2004 Feb; 9(1):59-63. PubMed ID: 15162828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
    Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
    Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neoadjuvant chemotherapy followed by conization in stage IB2-IIA1 cervical cancer larger than 2 cm: a pilot study.
    de Vincenzo R; Ricci C; Fanfani F; Gui B; Gallotta V; Fagotti A; Ferrandina G; Scambia G
    Fertil Steril; 2021 Jan; 115(1):148-156. PubMed ID: 33092819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.
    Ferrandina G; Distefano MG; De Vincenzo R; Salutari V; Petrillo M; Scarciglia ML; Pietragalla A; Conte C; Scambia G
    Gynecol Oncol; 2013 Mar; 128(3):518-23. PubMed ID: 23237767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.